Save time and money with
Med Tech Market
Research
MedTech Business intelligence
supplied by GlobalData
EpiCast Report: Dry Eye Syndrome — Epidemiology Forecast to 2022
Publication Date: March 2013
More information & buy >>
(from GlobalData)
Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. It results in symptoms of discomfort such as visual disturbance and tear film instability (DEWS, 2007).
Middle-aged and older adults are the most commonly affected group
because of the high prevalence of contact lens usage, systemic drug
effects, autoimmune diseases, and refractive surgeries in these group
(Davis, 2003; Glasson et al., 2003; Schaumberg et al., 2002; Schaumberg
et al., 2003; Toda et al., 2001).
Globally, dry eye has a
prevalence of up to 33% (Clegg et al., 2006; Lemp et al., 2008;
Schaumberg et al., 2002; Shimmura et al., 1999). The prevalence of dry
eye is estimated to range from <0.1% to 33% across different countries
and varies between 5% to >30% in various ages groups worldwide (Clegg et
al., 2006; Lemp et al., 2008; Shimmura et al., 1999). Research also
shows that dry eye syndrome is more prevalent in women than in men
(Schaumberg et al., 2002).
Scope
- The Dry Eye Syndrome EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of dry eye syndrome in the nine major markets (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It also includes a 10-year epidemiology forecast of the prevalent cases of dry eye syndrome, segmented by age (given in five-year increments beginning at age 45 years and ending at ages 85 years and older), sex, and severity in these markets.
Reasons To Buy
- Develop business strategies by understanding the trends shaping and driving the global dry eye syndrome market.
- Quantify patient populations in the global dry eye syndrome market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups, sex, and severity levels that present the best opportunities for dry eye syndrome therapeutics in each of the markets covered.